Wellbutrin Antitrust Class Survives Bid To Nix Cert.
A class of indirect purchasers of depression medication Wellbutrin XL and its generic equivalent on Monday beat a motion to nix class certification in their antitrust suit accusing GlaxoSmithKline PLC and...To view the full article, register now.
Already a subscriber? Click here to view full article